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Abstract 
Problem: Asthma affects one out of every ten children in the United States.  It is recommended 
that children with persistent asthma take long-term controller (LTC) medications to achieve 
control.  However, adherence varies, and many children do not take their LTC medication at all.  
The average cost for hospitalization of a child with asthma is $8,406.  Asthma in children also 
contributes to school absenteeism and a decrease in quality of life.   
Objective: A literature review was performed to examine factors that affect adherence to LTC 
medications used to control asthma in children.   
Method: A literature review was performed using the CINAHL, ERIC, Medline, Psych Info, and 
Academic Search Premier databases.  Keywords included asthma AND child* OR pediatric* 
AND adherence OR compliance AND corticosteroid* OR “leukotriene modifier*” OR “mast 
cell stabilizer*” OR “monoclonal antibod*” OR “long-acting beta agonist.*”  After applying 
exclusion criteria 35 articles were included in this review.     
Results: A variety of factors that affect adherence were identified.  Internal factors included age, 
sex, and race/ethnicity.  External factors included socioeconomic status, environment, health 
perception, lack of motivation, parental education, disease/medication beliefs, family dynamics 
and planning, responsibility, severity, and exacerbations.  Interventional factors included 
caregiver-family communication, asthma knowledge, specialty care, white coat adherence, 
number of prescriptions, asthma action plans, medication regimens, and technology.   
Conclusion: It is recommended that healthcare providers use a four-step process during inpatient 
and outpatient asthma visits.  The steps include assess and educate, collaborate, problem-solve, 
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and follow-up.  Collectively, this method can help healthcare providers overcome many of the 
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Symptoms exhibited by people with asthma are a manifestation of underlying 
inflammatory processes.  The airways of people with asthma contain excessive amounts of 
inflammatory cells including: mast cells, eosinophils, neutrophils, and macrophages.  These cells 
and many others have been identified in the pathophysiology of asthma.  Immunoglobin E (IgE) 
are antibodies that are abundant during allergic responses that may trigger asthma.  They activate 
other cells including mast cells.  Mast cells contribute to bronchoconstriction.  Smaller airways 
decrease the amount of air that is able to traverse through the bronchioles (National Heart, Lung, 
and Blood Institute [NHLBI], 2007.   
Macrophages in the airways are also activated by IgE antibodies, and they increase 
inflammation.  Eosinophils and epithelial cells that line the airways also contribute to 
inflammation.  The inflammation can have a negative effect on the smooth muscle in the airways 
causing hypertrophy which may decrease the size of the airways and contractions that can 
obstruct airflow (NHLBI, 2007).   
Inflammation involved in the pathophysiology of asthma is complex and not fully 
understood.  What is understood is that inflammation contributes to bronchoconstriction, airway 
hyper-responsiveness and obstruction.  This causes the hallmark symptoms of asthma which are 
coughing, wheezing, breathlessness, and chest tightness.  Over time, permanent changes to the 
airway, known as airway remodeling, can also occur (NHLBI, 2007).    
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Asthma Today  
According to the most recent data, there are 25.7 million people in the United States that 
have asthma, and its incidence is increasing.  It is more common among women than men, and is 
more prevalent in the poor.  There is also racial disparity with 16% of Porto Ricans, 11% of 
blacks, 8% of whites, and 5% of Mexicans having asthma.   
In one year, asthma accounted for more than 10 million outpatient visits, more than 2 
million emergency department (ED) visits, and more than 450,000 hospital admissions (National 
Center for Health Statistics [NCHS], 2012).        
There are seven million children in the United States that currently have asthma.  It is 
more prevalent among boys than girls.  Children account for more ED visits and hospitalizations 
than adults even though the number of adults with asthma far surpass that of children.  More than 
half of the children with asthma had an exacerbation in the year preceding data collection.  More 
than half of the children also missed school due to the disease (NCHS, 2012). 






The most recent guidelines for the diagnosis and treatment of asthma were published by 
the NHLBI in 2007.  According to these guidelines, the purpose of asthma treatment is to 
achieve specific goals.  The first goal is to prevent symptoms such as coughing, wheezing, and 
shortness of breath.  The second goal is to reduce the use of rescue medications to less than two 
times per week.  The third goal is to maintain lung function as close to normal as is possible.  
The fourth goal is to maintain normal physical activity.  The fifth goal is to prevent 
exacerbations and subsequent ED visits or hospitalizations.  The next goal is to prevent any 
lessening in lung growth.  The final goal is to provide optimal therapy with minimal side effects.  
Healthcare providers (HCPs) can determine if these goals are met when they assess asthma 
control. 
   Asthma control is classified as “well-controlled,” “not well-controlled,” or “poorly 
controlled.”  For children, control is based on frequency of symptoms, frequency of nighttime 
awakening, frequency of rescue medication use, frequency of exacerbations that require oral 
corticosteroids, and how much symptoms interfere with physical activity (NHLBI, 2007).   
For children above the age of five, control is also based on an objective assessment of 
lung function.  For children above the age of 12, control is also based on data collected in a 
questionnaire.  Optimally, asthma should be well-controlled.  The regimen used to control 
asthma also depends on disease severity (NHLBI, 2007).   
Asthma can be further classified based on disease severity.  Asthma severity is classified 
as either intermittent or persistent.  Persistent asthma is further classified as “mild,” “moderate,” 
or “severe.”  Severity is based on the same parameters used to determine asthma control.  The 
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best way to control persistent asthma is by incorporating the use of long-term controller (LTC) 
medications into the plan of care.  LTC medications are taken regularly to prevent exacerbations 
and improve control (NHLBI, 2007).   
Guidelines identify several medications that are indicated for long-term control of 
asthma.  All medications have some effect on inflammatory processes.  The first and most 
effective class of medications include the inhaled corticosteroids (ICSs).  They are not the same 
as the oral corticosteroids which produce a systemic effect (NHLBI, 2007).   
The next class of medications are mast cell stabilizers including cromolyn sodium and 
nedocromil.  They are used as alternative medications, and are not preferred therapies.  The next 
class of medications are the immunomodulators.  Included in this class is omalizuab which is a 
monoclonal antibody.  This class is only recommended if other regimens are unsuccessful 
(NHLBI, 2007).   
The next classification of medications are the leukotriene modifiers.  These medications 
are also designated for use as alternative medications, and are not preferred therapies.  The next 
classification includes inhaled long-acting beta2 agonists (LABAs).  They are not recommended 
as monotheraphy, and should be used in conjunction with another medication (NHLBI, 2007).   
The final classification of medications are methylxanthines including theophylline.  
Again it is suggested that these medications be used as an alternative, and not preferred therapy.  
These medications are used to control persistent asthma and achieve therapeutic goals (NHLBI, 





Poor Adherence  
 Many children with asthma do not take their medication at all.  Statistical data collected 
by the NCHS in 2012 determined that 60% of children with asthma had persistent asthma.  
Another 38% of children with asthma had uncontrolled asthma.  Only 40% reported that they had 
used a LTC medication in the three months prior to data collection, and 19% overused rescue 
medications.   
This was consistent with data collected in 2011 when Arellano, Arana, Wentworth, 
Vidaurre, and Chipps evaluated prescription fill patterns for 659,159 children with asthma.  They 
determined that 40% of the participants never received their initial prescription.  Children in this 
study were between the ages of 6-18, and all of them were insured.  This is also consistent with a 
study published by Wijga et al. in 2014.  Parents of 229 children with asthma participated in the 
study.  There were 170 children who were taking ICSs.  In a questionnaire given to parents it was 
determined that 15% of parents avoided giving their child the medication, and another 25% of 
parents discontinued the medication.      
Schultz et al. (2012) determined that when caregivers report adherence it is unreliable.   
They monitored medication adherence in 132 children with asthma using inhalers with electronic 
monitoring capability.  Adherence was as low as 0% and as high as 100%.  Generally, parents 
who reported that they missed doses missed at least half of them.  Also, parents that reported that 
they did not miss any doses missed at least 20% of them.       
 Duchame et al. (2012) reported that when medication is used to control asthma, it is not 
used consistently with caregivers only claiming 51% of their child’s ICSs.  In 2014, Mosnaim et 
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al. electronically monitored adherence in minority children with asthma.  They found that 76% 
did not even take half of their prescribed doses.  Chan et al. (2015) showed that adherence in 
children taking ICSs was as low as 8%.  Inconsistent adherence was also observed by Al-Muhsen 
et al. (2015) when they interviewed the caregivers of 297 children with asthma in an ED.   
Seventy-three percent of the caregivers reported that they stopped giving their child ICSs when 
symptoms improved.   
 Al-Muhsen et al. (2015) found that 40% of caregivers either started or increased the 
dosage of ICSs when their child was having an exacerbation.  This was also observed by Wijga 
et al. in 2014.  Forty percent of caregivers only gave their child ICSs when their child was 
symptomatic.  This was also observed by Sloan, Gebretsadik, Wu, Michel, and Hartert (2012).  
They evaluated prescription fill patterns among children with asthma.  Their data showed that 
there was a trend in which ICSs were obtained at the same time that caregivers were obtaining 
rescue medications used to treat an exacerbation.  Poor adherence is problematic because it can 
contribute to poor control.   
Poor Adherence and Poor Control  
In 2014, Baddar, Jayakrishnan, and Al-Rawas examined asthma control in 218 
participants.  They found that 83% of the participants that had poor medication adherence also 
had poor asthma control.  This was supported by Klok, Kaptein, Duiverman, and Brand in 2014 
who electronically monitored adherence in 81 children with asthma, and determined that children 
with well-controlled asthma had a median adherence above 80%.    
In 2015, Al-Muhsen et al. found that if caregivers started or increased ICS usage when 
their child was having an exacerbation, that child was three times more likely to have 
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uncontrolled asthma.  Children who were not taking an ICS were also more likely to have 
uncontrolled asthma.  Poor medication adherence and the resulting poor control contribute to 
increased healthcare utilization including emergency services.   
Poor Adherence/Poor Control and the Corresponding Increase in Healthcare Utilization 
Emergency department.  
Deis, Spiro, Jenkins, Buckles, and Arnold (2010) found that medication adherence was a 
factor in ED utilization.  They included caregivers of 108 children with persistent asthma.  When 
asked about their use of ICSs 49% percent of caregivers reported that they did not use ICSs 
daily.    
Rust, Zhang, and Reynolds (2013) evaluated the ratio of LTC medications to total asthma 
medications and its effect on ED utilization among children with asthma covered by Medicaid.   
Children who used more rescue medications were 21% more likely to have an ED visit and 70% 
more likely to be admitted than children who used more LTC medications than rescue 
medications.   
Supporting evidence was provided by Al-Muhsen et al. (2015) who found that children 
with uncontrolled asthma visited the ED more that those with controlled asthma.  Despite this, 
the majority of caregivers were not giving their child the medication necessary to achieve 
control.  Emergency department utilization remains a costly problem for children with asthma.      
Costs of emergency department. 
Wang, Srebotnjak, Brownell, and Hsia published data in 2014 that determined just how 
costly.  They received data from almost 3 million ED visits in which costs ranged from $19 to 
$12,601.  Participants were between the ages of 0-85.  Yet, children between the ages of 0-19 
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made up 48% of the sample.  The average costs for an ED visit among children with asthma are 
displayed in Table 1.      
 
Average Cost for Emergency Department Visits  
by Insurance Type in Children Aged 0-19 
Medicare Medicaid Uninsured Private  
$414 $1,108 $1,120 $1,263 
Table 1 ED Costs 
Hospitalization. 
Exacerbations may require frequent hospitalization.  In 2014, Auger, Kahn, Davis, and 
Simmons examined hospital readmission among 601 children with asthma between the ages of 
1-16.  The five year study found that children were more likely to be readmitted if their 
caregivers reported any lapse in medication adherence or if they did not answer questions related 
to adherence at all.     
Costs of hospitalization.  
 In 2013, Hasegawa, Tsugawa, Brown, and Camargo evaluated the costs of asthma 
hospitalizations from 2000-2009.  According to the data collected, the costs have increased from 
1.3 billion in 2000 to 1.6 billion in 2009.  In 2009, there were 305,000 admissions that were an 
average of two days.  The average cost of hospitalization was $8,406.    
Poor Control and Quality of Life 
Besides monetary repercussions, poor asthma control has also been shown to have a 
negative effect on quality of life in children.  Almost half of the children with asthma had missed 
school due to their asthma, and 60% of people with asthma limit their physical activity (NCHS, 
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2012).  In 2013, Li et al. published a study to determine if asthma control affected sleep in 160 
children.  They found that poor asthma control was also associated with daytime sleepiness.    
Summary of Problem 
 To summarize the concepts presented, the primary problem is that adherence to 
medications used to control asthma is poor.  Some children do not take any medication at all.  
Those who do often fall short of the 80% that is recommended to maintain asthma control.  
Children that do not adhere to LTC medications are more likely to have uncontrolled asthma.  
Those with uncontrolled asthma are more likely to visit the ED or be hospitalized.  This results in 





The purpose of this research is to determine the different factors that affect adherence to 
LTC medications used to manage asthma in children.  A literature review was performed to 
examine the current evidence.  Factors will be identified that either increase or decrease 
adherence, and the findings will be discussed.   
The secondary purpose of this research is to make recommendations for current practice 
and future practice based on the findings in this study.  The final purpose of this research is to 
make recommendations for future research based on the findings of this study.   
Overall, the purpose of this research is identify a method to improve the way that HCPs 
care for children with persistent asthma in order to decrease costs and increase the quality of life.      
   





A literature review was performed using the CINAHL, ERIC, Medline, Psych Info, and 
Academic Search Premier databases.  Keywords included asthma AND child* OR pediatric* 
AND adherence OR compliance AND corticosteroid* OR “leukotriene modifier*” OR “mast 
cell stabilizer*” OR “monoclonal antibod*” OR “long-acting beta agonist.*” This produced a list 
of 305 articles.  Articles were included only if they met specific criteria.   
Articles were included only if the publication was in English.  Articles that were written 
in foreign languages were excluded.  Any duplicate articles were also excluded.    
Articles that were published in or after 2010 were included in this review.  Articles 
published prior to 2010 were excluded.   
Primary sources were included in this review.  Randomized, controlled trials, controlled 
trials without randomization, case-studies, cohort studies, and qualitative studies were included.  
Secondary sources were excluded to prevent further degradation of content.  
Articles that contributed to the research question were included in this review.  Articles 
had to identify factors associated with adherence to long-term medications given to control 
asthma in children.  Articles were excluded if they did not identify specific factors.  Articles 
were also excluded if they focused on healthcare provider adherence to recommendations.     
Articles that included pediatric participants between the ages of 0-18 were included in 
this review.  Any articles that included adult participants were excluded from this review even if 
pediatric participants were also involved in the research.   
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Articles that included children diagnosed with asthma were included in this review.  
Articles that included children also diagnosed with other diseases were also included in this 
review.  Articles were excluded if participants had respiratory distress or wheezing, but were not 
diagnosed specifically with asthma.    
The search yielded 305 results.  After apply exclusion criteria 270 articles were 
eliminated.  The remaining 35 articles were included in the literature review.  
Figure 1 Method 
     
305 articles were 
identified 
91 repeated articles 
were eliminated
214 articles remained




85 articles that did 
not answer the 
reserch question were 
eliminated




Over 20 factors were identified that affect adherence to LTC medications used to manage 
asthma in children.  They have been organized into three categories that include internal factors, 
external factors, and interventional factors.  Inherent characteristics were classified as internal.  
Factors that were neither inherent nor controlled by HCPs were classified as external.  Factors 
that HCPs have control over were classified as interventional.   
Internal Factors  
Age.  
Several different studies have evaluated age and its correlation with adherence to LTC 
medications.  Studies included various age ranges and populations.   
In 2014, Capo-Ramos, Duran, Simon, Akinbami, and Schoendorf examined prescription 
fill patterns to ascertain adherence among children with Medicaid.  Participants were between the 
ages of 2-17, and they were taking LTC medications used to treat persistent asthma.  There were 
a total of 4,262 participants with the majority being male and white.  The researchers determined 
that adherence declined over time, and only 15% of the participants were still receiving 
medications 190 days after the initial prescription was filled.   
Capo-Ramos, Duran, Simon, Akinbami, and Schoendorf (2014) also found that there was 
a higher likelihood of non-adherence among toddlers between the ages of 2-4 and adolescents 
between the ages of 12-17.  Herndon et al. (2012) also found an association between children 
between the ages of 2-4 and non-adherence.   
Contradictory to these studies, Elkout et al. (2012) showed higher adherence among 
children aged 0-4 taking ICS when compared to all other age groups.   
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Koster, Raaijmakers, Vijverberg, and der Zee (2011) evaluated ICS adherence among 
children with asthma in the Netherlands between the ages of 4-12.  They found that adherence 
was higher in the children under the age of six when compared with older children.  To 
complicate the findings more, Vasbinder et al. (2014) did not show a statistically significant 
difference in adherence among children between the ages of 1-11.  One weakness in this study 
was that participants knew that they were being monitored, and they may have adjusted their 
behavior based on this knowledge.   
Mosnaim et al. (2014) evaluated adherence to ICSs in 93 minority adolescents between 
the ages of 10-16.  The average age for adherence greater than 50% was 12.  The average age for 
adherence less than 50% was 13.  This corresponds with data published by Capo-Ramos et al. in 
2014 that found an association between older adolescents and non-adherence. 
Overall, results vary between the different studies.  There is one consistency.  That is the 
association with older adolescents above the age of 13 and non-adherence.  This may be due to 
problems with delegation of responsibility which are evaluated later on in this review.        
Sex. 
Childhood asthma disproportionately affects boys (NCHS, 2012).  Most of the studies 
included had more male participants, consistent with this unequal distribution.     
In 2010, Sawicki et al. evaluated adherence in 425 children with asthma who were 
prescribed ICSs. The study spanned five years, and adherence declined over the span of the 
study.  Adherence was self-reported and classified as consistent, variable, intermittent, or none.  
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After the first year it was determined that consistent adherence occurred more frequently in girls.  
One limitation was that adherence was self-reported (Schultz et al., 2012).   
In 2012, Elkout, Helms, Simpson, and McLay investigated adherence to LTC 
medications in 3,172 children with asthma.  Adherence to various LTC medications was 
determined by medication possession.  In this study, adequate adherence was medication 
possession between 80-120% of the prescribed regimen.  The researchers determined that 
adequate adherence was higher in boys for all classes of medication.  Overall, 58% of those with 
adequate adherence were male.  However, 62% of their participants were boys.  That is 
indicative of higher adherence in girls.   
In 2014, Mosnaim et al. examined adherence to ICSs in 93 minority adolescents between 
the ages of 10-16.  Adherence was determined by medication possession.  Their study population 
was 44% male.  However, only 24% of males had adherence greater than 50%.  Data collected in 
this study showed that girls were statistically associated with higher adherence.  
Herndon et al. (2012) had varying results.  They evaluated adherence among 18,456 
children with Medicaid using claims data.  Higher adherence was found in 60% of the boys 
taking ICSs.  However, boys accounted for 60% of the participants taking ICSs.  They also 
evaluated adherence to leukotriene modifiers.  Boys accounted for 64% of the participants who 
were taking leukotriene modifiers, but they accounted for 64% of the participants with higher 
adherence.  For leukotriene modifiers boys were slightly more likely to have better adherence.    
Overall, there are multiple studies that indicate that adherence in girls is superior to that 




In 2011, Koster et al. evaluated ICS adherence among children in the Netherlands 
between the ages of 4-12.  There were 527 children who participated in the study.  Data obtained 
determined that good adherence was reported more often in native Dutch children when 
compared with other children.  One limitation was that adherence was self-reported (Schultz et 
al., 2012).   
In 2014, Vasbinder et al. also examined adherence to ICSs in children between the ages 
of 1-11 in the Netherlands.  The purpose of the study was to determine if there were differing 
levels of adherence between native Dutch participants and Moroccan participants.  They 
measured adherence electronically.  They found that adherence among the native Dutch was 
higher than that of Moroccan children.  Adherence among the native Dutch was 56%.  The 
average adherence for Moroccan participants was 42%.     
There have also been studies that evaluate how race and ethnicity affect adherence here in 
the United States.  Herndon et al. (2012) evaluated adherence among 18,456 children in the 
United States using Medicaid claims data.  Adherence was lower in the black and Hispanic 
participants when compared to white participants.  This trend was repeated in the study by Capo-
Ramos et al. in 2014.  They evaluated adherence among 4,262 children with Medicaid using 
prescription fill patterns.  They also found that adherence was lower in the black and Hispanic 
participants when compared to the white participants.  
Another contributory study by Martin, Olson, Mosnaim, Ortega, and Rothschild (2012) 
specifically examined 101 Puerto Rican children with asthma living in the United States.  
Overall, adherence was poor.  It was determined that 69% of the children in the study did not 
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have well-controlled asthma in the preceding month.  However, only 29% of them reported that 
they used a medication to control asthma, and had the medication in the house.   
The studies consistently showed that adherence is higher in white children when 
compared to other races and ethnic backgrounds.  Barriers to adherence may be different 
depending on the different populations.     
External Factors  
Socioeconomic status. 
In 2012, Elkout et al. examined adherence among 3,172 children with asthma.  
Adherence was determined using medication possession.  They did find an association between 
socioeconomic status and adherence.  Socioeconomic status was determined using the Sottish 
Index of Multiple Deprivation (SIMD). Results that were between 0-5 indicated low 
socioeconomic status, and results that were between 6-10 indicated high socioeconomic status.   
Among those with adequate adherence, 54% were of high socioeconomic status.  The 
lower adherence observed in participants with lower socioeconomic status may be due to the 
higher costs associated with asthma.  In 2010, Barnett and Nurmagambetov determined that 
asthma costs an individual approximately $3,259 annually including $1,680 in medication 
expenses.  
Environment. 
Herndon et al. (2012) also found an association between environment and adherence.  
Using Medicaid claims data, they found that among their 18,456 participants 35% of the 
participants living in rural areas had poor adherence.  Poor adherence among participants living 




Herndon et al. (2012) showed that the higher participants perceived their health the lower 
their compliance.  This study involved 18,456 children with asthma who were covered by 
Medicaid.  Capo-Ramos et al. (2014) did not see this trend repeated in their research.  They also 
evaluated children with asthma who were covered by Medicaid.  Their study included 4,262 
participants.  They found no correlation between health perception and adherence.      
Lack of motivation. 
In 2014, Vella, Bezzina, and Urpani published data collected in a survey of children with 
asthma.  There were 131 participants between the ages of 7-15.  Among those who reported non-
adherence, 76% reported that their lack of adherence was due to indifference.  This study differs 
from the other studies that incorporate surveys into their research, because it gives the sole 
perspective of the older child with asthma, rather than data reported by caregivers.   
Parental education.  
In 2011, Koster et al. studied 527 children from the Netherlands between the ages of 4-
12.  Adherence in this study was self-reported.  Results from this study showed that, among 
participants that reported good adherence, there was an equal distribution of parents with higher 
and lower levels of education.  However, they did not specify what was considered a high 
education, and what was considered a low level of education.  Another weakness was that 
adherence levels were reported subjectively (Schultz et al., 2012).   
Capo-Ramos et al. (2014) did find an association between adherence and parental 
education.  They evaluated adherence among 4,262 participants with Medicaid.  Continued 
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adherence was more likely if parents had at least some college education.  Parents were more 
likely to discontinue LTC medications if they completed no higher than high-school education.   
This was supported by Vasbinder et al. in 2014.  Their study included 87 participants in 
the Netherlands.  Adherence was monitored electronically.  Children had higher adherence if 
their parents had completed college or university education when compared with children whose 
parents had completed no higher than vocational education, 59% and 45% respectively.   
Disease/Medication beliefs.  
In 2011, Koster, Raaijmakers, Vijverberg, and der Zee evaluated adherence to ICs among 
527 children in the Netherlands.  They found an association between medication beliefs and 
adherence.  Among those who reported good adherence, 67% highly believed that the medication 
was necessary.  One weakness was the use of self-reports (Schultz, 2012).  However, this 
concept has been reinforced by several other studies.   
In 2012, Klok, Kaptein, Duiverman, and Brand examined the effect that medication 
beliefs had on electronically monitored adherence among 93 children in the Netherlands between 
the ages of 2-6.  Overall adherence was high with a median of 92% adherence.  They also found 
that high adherence was associated with medication beliefs.  Parents were more adherent if they 
believed two things: the medication was necessary for their child, and there was little risk for 
harm.   
This concept was also identified by Wijga et al. in 2014.  Adherence to LTC medications 
was assessed in 229 participants.  Reported adherence was higher when parents felt that the 
medication was important for their child.  However, self-reports were again used (Schultz, 2012).   
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Klok, Kaptein, Duiverman, and Brand (2014) observed that parents were more adherent 
if they believed that their child needed the medication and the risk of harm was minimal.  Non-
adherence occurred if parents were concerned about the side effects of the medications.  Those 
parents would intentionally give their child less medication when symptoms improved.   
Schultz et al. (2012) evaluated 132 families, and adherence was electronically monitored.  
Parents were interviewed to determine barriers to adherence.  Parents in this study reported that 
they intentionally stopped administering the medication to see if their child needed it.  That 
supported previous data that indicated that adherence is improved when parents believe that their 
child needs the medicine.   
Parental concerns about medications was also determined to affect adherence when 
Armstrong, Duncan, Stokes, and Pereira (2014) studied adherence among 43 preschoolers with 
asthma in the southern United States.  The children included in this study were predominantly 
white and male.  Adherence was determined using subjective data, and then compared to 
prescription fill patterns.  Medication beliefs were determined using a questionnaire developed in 
prior asthma research.  Data obtained showed that negative medication beliefs were associated 
with non-adherence.  As negative medication beliefs increased adherence decreased.   
Vella et al. (2014) assessed adherence among 131 children between the ages of 7-15 
taking ICSs.  Twenty percent of children who reported non-adherence reported that it was 
because they felt the medications were unnecessary.  Eighteen percent of the participants also 
believed that it was okay to stop the medication in the summer, and an additional 7% reported 
that they reduced the dosage.  According to Al-Muhsen et al. (2015), these children are three 
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times more likely to have uncontrolled asthma, and children with uncontrolled asthma are more 
likely to visit the ED.  They provided the perspective of the older children, many of whom have 
taken responsibility for their own medication administration.   
Contradicting all of the previous studies, Vasbinder et al. (2014) did not find an 
association with medication beliefs and adherence when they evaluated 87 children with asthma 
in the Netherlands.  Results from this study did not show statistically significant adherence 
among participants whose beliefs ranged from skeptical to accepting.   
Overall, most of the included studies emphasized the importance of assessing medication 
beliefs when planning care for children with asthma.  In 2010, Zedan, Regal, Osman, and Fouda 
interviewed the parents of 100 children with asthma.  Fifty-three percent of parents were 
concerned about medication side effects.  HCPs need to educate parents and older children about 
the medications that they are taking and overcome this powerful barrier to adherence.   
Family dynamics and planning.  
In 2012, Schultz et al. published a study in which adherence to ICSs were unknowingly 
monitored electronically for 132 children with asthma.   Parents that missed doses generally 
missed at least half of the prescribed doses.  Parents were then asked about their adherence.  
Parents then identified reasons for their inconsistency.   
The most frequent responses were due to forgetfulness, child refusal, or being too busy.  
Some parents reported that their children fell asleep prior to medication administration.  Others 
reported that medication may not be administered properly when the child is with another 
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caregiver.  These concepts identify the importance for the HCP to anticipate these problems, and 
assist with problem-solving and planning (Schultz et al., 2012).   
In 2014, Klok, Lubbers, Kaptein, and Brand evaluated reasons behind medication 
adherence and non-adherence among children with uncontrolled asthma in the Netherlands.  
There were 135 families that participated in the study, and children were between the ages of 2-
12.  Researchers fist objectively monitored adherence electronically.    Afterwards they 
interviewed ten families that had adherence above 75% and ten families with adherence below 
75%.   
In families with non-adherence there were a lot of the same reasons that have already 
been identified.  Parents reported that they may forget to give a dose, or skip a dose when their 
child refuses it.  Among families with higher adherence there was more planning.  For example, 
parents would create a routine in order to avoid forgetting to give the child their medication 
(Klok, Lubbers, Kaptein, and Brand, 2014).   
Capo-Ramos et al. (2014) also found an association between children non-adherence and 
family dynamics, although their results were different from those that were already discussed.  
Single-parent families, with three or more children, had a higher risk for non-adherence when 
compared to families that had two parents and less than three children.   
This was studied to a lesser extent by Renov in 2014.  There were 58 families included 
that were taking ICSs.  The study found no statistically significant difference in adherence when 
comparing single parent families to dual parent families.  However, this research did not examine 
the number of children in the families.       
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Armstrong et al. (2014) did not find a statistically significant correlation between parental 
stress and medication adherence when they studied the families of 43 preschoolers with 
persistent asthma.   
HCPs should anticipate these potential problems.  They also need to collaborate with 
families and identify any barriers to medication administration.  This collaboration can help to 
increase adherence (Rohan et al., 2013).  
Responsibility.  
Klok et al. (2014) objectively monitored medication adherence among 135 children with 
asthma between the ages of 2-12.  Afterwards they split participants into two groups.  One group 
had adherence greater than 75%.  The other group had adherence less than 75%.  Researchers 
interviewed the families to determine reasons for non-adherence.  They found that many older 
children were given the responsibility to take their own medications.   
Families with additional stressors gave their children the responsibility at a younger age.  
Among the families that had adherence greater than 75% responsibility was given to older 
children gradually.  Parents also continued to supervise medication administration.  In situations 
where parental supervision caused conflict they would be more subtle about overseeing their 
child’s medication administration (Klok et al., 2014).   
Klok et al. (2014) also determined that in families with adherence less than 75% some 
parents were unaware of their child’s non-adherence.  Others relied on their doctor to intervene.  
The data showed that the shift in responsibility from parent to child can be hazardous time for 
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medication adherence.  It should occur gradually, and parents should resume responsibility if the 
child is unable to maintain adherence.   
This is supported by Rohan et al. (2013).  Adherence among all of the children in the 
study improved with the exception of a nine-year old whose parent did not resume responsibility 
for medication administration when adherence began to decline.  Adherence for this child 
continued to decline.     
 The positive effect of a gradual shift in responsibility is supported by Duncan et al. 
(2012).  They examined the effectiveness of an intervention used to increase medication 
adherence in 48 children with asthma between the ages of 9-15.  The purpose of the study was to 
determine if the gradual shift in medication responsibility using a teamwork approach between 
parents and older children would improve adherence.   
Children were divided into three groups.  Group one utilized the teamwork intervention 
led by therapists.  This intervention involved teaching parents and children about development, 
independence, expectations, communication, and teamwork.  At the beginning of the 
intervention children were supervised, and gradually medication responsibility was transferred 
depending on their level of adherence.  Group two provided an educational intervention in which 
families were educated about asthma.  Group three was the control group.  Over the 20 weeks of 
the study adherence declined in all three groups.  However, adherence in group one was the 
highest.  Initially, it was 90%, and it was reduced to a low of 81% after 20 weeks.  In group two 
adherence was 59%.  It was gradually reduced to 33% after 20 weeks.  Adherence in the control 
group was 67%.  It gradually decreased to 37% after 20 weeks.   Overall, the teamwork 
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promotion intervention resulted in the highest levels of medication adherence. This intervention 
shows that adherence can be maintained above 80% when the child gradually assumes 
responsibility for medication administration (Duncan et al., 2012).     
Severity. 
In 2010, Sawicki et al. studied adherence in 425 children with asthma who were 
prescribed ICSs. The study spanned five years, and adherence declined over the span of the 
study.  Adherence was self-reported and classified as consistent, variable, intermittent, or none.  
After the first year, consistent adherence was determined to occur more in those with moderate to 
severe asthma.   
These results were supported by Zhang, Taylor, Sazonov, Thomas, and Price in 2011.  
They included 2,220 children with asthma between the ages of 2-14.  Adherence was determined 
using prescription fill patterns, and it was monitored for a year.  Children with mild persistent 
asthma had the worst adherence.  Fifty-five percent of them had discontinued medication by the 
end of the year.  Adherence was better in children with moderate persistent asthma, and 
adherence was best in children with severe persistent asthma.  Only 41% of them had stopped 
receiving medication by the end of the year.    
These results were replicated by Klok, Kaptein, Duiverman, and Brand in 2014.  They 
electronically monitored adherence in 81 children with asthma.  Overall adherence in this study 
was high, between 74-95%.  Adherence among children with mild intermittent symptoms was 
lowest, 74%.  Adherence in children with uncontrolled moderate to severe symptoms was 
highest, 95%.  
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These studies have all determined that adherence improves as disease severity increases.  
This may be because medication is more likely to be perceived as necessary in children who are 
more symptomatic.     
Exacerbations. 
In 2013, Sloan, Gebretsadik, Wu, Michel, and Hartert examined adherence to ICSs 
among 51,725 children with asthma covered by Medicaid.  During this five-year study, 
adherence was determined using prescription fill patterns.  The researchers determined that 37% 
of ICS were dispensed at the same time that rescue medications were dispensed.  Based on this 
data, they determined that adherence to LTC medications increased when there was an 
exacerbation, and was reactive rather than proactive.   
Elkout, Helms, Simpson, and McLay (2012) evaluated adherence to LTC medications 
among 3,172 participants.  They found an association between higher adherence and those who 
obtained greater than six rescue medications annually.  Sloan et al. (2013) determined that 37% 
of LTC medications were dispensed at the same time that SABAs were dispensed, and adherence 
was triggered by an exacerbation.  The higher adherence that was observed by Elkout et al. is 
likely because children receiving greater than six rescue medications annually have more 
exacerbations than those who require less.    
Interventional  
Caregiver-Family communication.   
Communication and problem-solving may contribute to increased adherence to LTC 
medications over time.  This was demonstrated by Sleath et al, in 2012.  They examined 259 
children between the ages of 8-16 with persistent asthma.  First, they recorded a visit with the 
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family and their HCP.  They were trying to determine if HCPs complied with national guidelines 
that recommend that family input be included when developing a plan of care.   
They found that the child’s input was only asked for in 8% of visits and the caregiver’s 
input was only asked for in 9% of the visits.  A month after the visit the family was interviewed 
to assess adherence.  Adherence was self-reported.  Researchers found that there was statistically 
significant higher adherence in the families if HCPs asked for their input when developing the 
plan of care (Sleath et al, 2012).   
This was also demonstrated by Rohan et al. in 2013.  Pediatric psychologists taught HCP 
how to provide feedback about ICS adherence and problem-solve with families.  Eleven families 
were included in the study and children were between the ages of 5-14.  Families were divided 
into the intervention group in which HCP incorporated their training about adherence feedback 
and problem-solving.  The other participants were divided into the control group.   
In the intervention group, routine asthma care involved feedback about electronically 
monitored adherence, identification of barriers to medication administration, and problem-
solving.  Adherence increased from a baseline adherence of 31% to an intervention adherence of 
57%.  After completion of the intervention adherence dropped to 26% (Rohan et al., 2013).   
Adherence and problem-solving can be an effective tool to increase adherence.  This is 
supported by Wijga et al., (2014) who reported that parents reported higher adherence when they 
felt that had received enough information from their HCP.  However, enhanced communication 
cannot be used independently to increase adherence above 80%.      
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Asthma knowledge.  
In 2012, Duncan et al. instilled an educational intervention to determine if it had any 
effect on adherence.  Participants were between the ages of 9-15 and adherence was 
electronically monitored over 20 weeks.  In children who received an educational intervention, 
adherence gradually declined from 59% to 33%.  In the control group, adherence gradually 
declined from 67% to 37%.  However, the study did not evaluate the knowledge of the 
participants.   
In 2014, Mosnaim et al. examined adherence to ICSs among minority adolescents with 
asthma.  There were 93 participants between the ages of 10-16.  Adherence was electronically 
monitored over two weeks and children were divided into a group that took more than half of 
their prescribed medication and a group that took less than half of their prescribed medication.  
Children who took more than half of their medication scored higher on a questionnaire used to 
determine knowledge about ICSs.  
This was also demonstrated by Wijga et al. in 2014.  The study included 229 participants 
and their families.  A questionnaire was used to determine parental knowledge about ICSs.  
Reported adherence was 84% for parents who knew that the ICSs should be taken daily.  
Reported adherence was only 25% for parents who did not now that the ICSs should be taken 
daily.  Unfortunately, adherence in this study was self-reported (Schultz et al., 2012).   
In 2010, Klok, Brand, Bomhof-Roordink, Duiverman, and Kaptein evaluated adherence 
among children with asthma who were going to primary or secondary care facilities.  For the 
purposes of this study primary care represented a general pediatric facility, and secondary care 
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represented a pediatric asthma facility.  There were 44 participants, and children were between 
the ages of 2-12.   
Reported adherence was higher in the secondary group.  Parents in the secondary group 
believed that the medication was necessary to suppress asthma and prevent exacerbations.  
Parents in the primary group believed that the medication would lose its effectiveness if given 
regularly.  Parents in the secondary group knew more about asthma medications which may 
contribute to their increased adherence (Klok, Brand, Bomhof-Roordink, Duiverman, and 
Kaptein, 2010).   
These studies suggest that knowledge about LTC medications used to manage asthma 
may be superior to general asthma knowledge in increasing adherence.      
White coat adherence. 
Keemink, Klok, and Brand examined white coat adherence in 2014.  White coat 
adherence is described as adherence that increases in the time period directly preceding a 
scheduled visit to the doctor.  The study was conducted in the Netherlands, and there were 78 
children included.   
Participants were between the ages of 2-6 and taking ICSs for asthma.  Adherence was 
electronically monitored, and the median adherence was 85%.  In 22% of the participants 
adherence did increase in the week prior to the scheduled outpatient visit.  However, adherence 
also decreased for 21% of the participants in the week prior to the visit.  This study shows that 
adherence may increase or decrease directly before a scheduled visit to the doctor (Keemink, 
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Klok, and Brand, 2014).  White coat adherence can account for the increase.  However, there 
was no explanation about the decreased adherence.   
Specialty care.  
In 2010, Klok et al. evaluated adherence among children with asthma who were going to 
a general pediatric facility and children who were going to a pediatric asthma facility.  There 
were 44 participants, and children were between the ages of 2-12.  Reported adherence was 
higher in the group that went to the asthma clinic.   
Bollinger et al. (2013) also evaluated how a specialist may affect adherence.  There were 
53 participants with persistent asthma included in this study.  They were between the ages of 2-8.  
The majority of the participants were black.  There were more males and most of the participants 
had Medicaid.  Prescription fill patterns were used to determine adherence.  They determined 
that 30% of the medications prescribed by the allergist were never filled.  However, non-
adherence was at least 10% lower in those who saw other HCPs.   
Both of these studies suggest that adherence is higher in children who see specialists 
rather than primary care providers.  However, one study reported that medication knowledge was 
higher in the group that saw the specialist (Klok et al., 2010) which may be the main factor 
contributing to the increased adherence.     
Number of prescriptions. 
In 2010, Pando et al. examined adherence to ICSs in children between the ages of 5-15.  
There were 2,355 participants in their Canadian study.  They determined adherence based on the 
amount of medication obtained compared with the amount of medication prescribed.  Almost 
half of the participants were not prescribed a refill.  Among those who were given one 
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prescription adherence was 100%.  Adherence dropped to 61% for participants who were given 
2-6 prescriptions.  Those who were given greater than seven prescriptions had the lowest 
adherence of 37%.   
Based on this study, the higher the amount of prescriptions the lower the adherence.  Data 
is consistent with other studies that show a gradual decrease in adherence over time.  Healthcare 
providers should schedule follow-up visits periodically in order to assess adherence, and 
determine if there are any barriers or problems with the medications that need to be overcome.       
Asthma action plans.  
An asthma action plan (AAP) is a written document that is created by a healthcare 
provider.  It is an individualized medication plan that is either symptom based, peak-expiratory 
flow based, or both.  Medication instructions are given to the patient and the family dependent on 
symptoms or PEF.  National guidelines recommend that all patients with asthma receive an AAP.  
This plan should be updated at every opportunity (NHLBI, 2007). 
In 2011, Ducharme et al. examined how receipt of an AAP affected adherence to ICSs 
over 28 days.  There were initially 219 participants between the ages of 1-17.  The majority of 
the participants were white, and there was an even distribution of public and private insurance.  
All of the participants were not prescribed ICSs over the entire timespan, and results were based 
on the amount of time medications were prescribed.   
Participants were divided into two groups.  The first group received a prescription and an 
AAP.  The control group only received a prescription.  Adherence was monitored using dose 
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counters.  Over the course of the 28 days there was higher adherence in the group that received 
the asthma action plan, and the gap increased over time.   
Over the first two weeks, adherence was 89% for those with the AAP compared to 86% 
in the control group.  Over the last two weeks adherence was 79% for those with the asthma 
action plan compared to 25% for those in the control group (Ducharme et al., 2011).  Based on 
these results, an AAP may be a key tool in increasing adherence, but it cannot be used 
independently to maintain adherence above 80%.    
Medication regimens.  
There are several studies that suggest that adherence varies depending on medication.  In 
2011, Zhang, Taylor, Sazonov, Thomas, and Price examined adherence among children with 
asthma in the United Kingdom.  There were 2,220 children included, and they were between the 
ages of 2-14.  They used prescription fill patterns to monitor adherence for a year.  Adherence 
was best for children taking fluticasone.  At the end of the year 59% of children were still 
receiving medication.   
Lesser adherence was observed among children taking beclomethasone.  At the end of the 
year 45% of children were still receiving this medication.  Budesonide had the least adherence.  
At the end of the year there were just 42% of children still receiving medication.  Out of all of 
the included ICSs fluticasone had the best adherence (Zhang, Taylor, Sazonov, Thomas, and 
Price, 2011).   
Herndon, Mattke, Cuellar, and Hong (2012) examined LTC medication adherence among 
18,456 children with asthma.  Children were Medicaid recipients and between the ages of 2-18.  
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Adherence was determined using prescription fill patterns.  Data obtained from this study 
showed that medication adherence was higher among children taking leukotriene modifiers when 
compared to children taking ICSs.  Adherence was 28% for those taking leukotriene modifiers 
and 20% for those taking ICS.  These results were consistent with those of several other studies.  
In 2012, Spray examined adherence to LTC medications among 244 families that had a 
child with asthma between the ages of 7-15.  Spray also found varying adherence depending on 
the type of medication prescribed.  Adherence for ICSs was 37%, and adherence for leukotriene 
modifiers was 56%.  
Elkout et al. (2012) also had similar results when they did a study that evaluated how 
medications may affect adherence.  Adequate adherence was defined as medication possession of 
80-120% of the prescribed regimen.  Thirty-nine percent of participants taking leukotriene 
modifiers had adequate adherence.  Adherence was lower among participants taking LABSs in 
conjunction with ICSs.  Less than 30% of them had adequate adherence.  The worst adherence 
was observed among participants taking ICSs as monotherapy.  Only 15% had adequate 
adherence.     
These results replicated by Durcharme, Noya, Allen-Ramey, Maiese, and Blais in 2012.  
They used claims data to monitor adherence among 227 children with asthma between the ages 
of 2-17.  Children included in the study were taking either ICSs or leukotriene modifiers.  Fifty-
one percent of the prescribed ICSs were claimed.  However, 74% of the leukotriene modifiers 
were claimed.  Once again, there was higher adherence among those taking leukotriene 
modifiers.   
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Bollinger et al. expanded on this in 2013.   They evaluated adherence using prescription 
fill patterns for 53 children between the ages of 2-8.  They found that 40% of children prescribed 
ICSs in conjunction with LABAs never filled their initial prescription.  For those prescribed 
monotherapy ICSs 31% never filled their initial prescription.  Consistent with previous literature, 
just 21% of those prescribed leukotriene modifiers did not fill their initial prescription.  This data 
shows that there is a medication regimen with less adherence than ICSs: ICSs with LABAs.    
Capo-Ramos et al. in 2014 also evaluated adherence with different medication 
modalities.  They included 4,262 children with asthma between the ages of 2-17.  Children were 
all enrolled in Medicaid, and adherence was determined using prescription fill patterns. They 
found that adherence was greater in participants who were prescribed ICSs in conjunction with 
leukotriene modifiers when compared to other medications.  
Data in these studies provide evidence that the prescribed medication does affect 
medication adherence among children with asthma.  Adherence is consistently highest for 
regimens that contain leukotriene modifiers.  Adherence is consistently lowest for monotherapy 
ICSs.  This represents a difficult situation for HCPs, because ICSs are the most effective 
medication for treating persistent asthma (NHLBI, 2007).   
Lower adherence for ICSs may be due to negative medication beliefs which do contribute 
to non-adherence (Armstrong et al., 2014).  Concerns about steroids among the parents of 
children with asthma may be as high as 53% (Zedan et al., 2010).  That represents a significant 
barrier that HCPs will need to anticipate and overcome to improve adherence.     
Symptom Diaries  
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In 2014, Arga, Sahbaz, Bakirtas, Turktas, and Demirsoy incorporated the use of symptom 
diaries into asthma management.  There were 340 children between the ages of 6-17 that were 
included in the study.  They found that children who kept symptom diaries were more likely to 
take LTC medications regularly.  Eighty-one percent of the children who kept symptom diaries 
took medications regularly as opposed to 58% of the children who did not keep symptom diaries.  
One significant weakness of this study is that medication adherence was self-reported (Schultz et 
al., 2012).     
Technology.  
In 2012, Feldman et al. evaluated the effect of peak expiratory flow (PEF) feedback 
among minority children between the ages of 7-15 living in the Bronx, New York.  PEF is an 
objective way to monitor lung function.  Children received an electronic peak flow device that 
gave audible reminders when it was time to check PEF.  In the intervention group, children 
estimated their PEF prior to using the device, and data was stored.  Afterwards, they used their 
device and compared their estimate to their actual PEF.  Children in the control group were 
unable to see their PEF.  The entire study included 192 children.   
Adherence to ICSs was monitored electronically in 95 of the included children.  In the 
intervention group that used the electronic peak flow device adherence to ICS was 49%.  In the 
control group the average adherence was 28%.  Incorporating the use of this technology 
increased adherence in minority children who had lower rates of adherence when compared to 
white children (Feldman et al., 2012).     
Giselle et al. (2013) evaluated a different kind of technology in an attempt to improve 
medication adherence among minority adolescents between the ages of 11-16 taking ICSs.  
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There were 34 participants, and they were divided into an intervention group and a control 
group.  The intervention group received mp3 players and attended weekly peer group support 
meetings.  After the meeting, the adolescents recorded supportive messages that were 
incorporated into the mp3 playlist.  The intervention lasted for 10 weeks.   
Adherence gradually declined from baseline in the intervention group and in the control 
group.  At five weeks adherence for the intervention group was 19%, and adherence for the 
control group was 16%.  At ten weeks adherence for the intervention group was 7%, and 
adherence for the control group was 14% (Giselle et al., 2013).   
This technology was not shown to be effective in increasing adherence.  There are a 
couple of factors that may have contributed.  One, in particular, is that the intervention depended 
on children listening to the supportive messages on their mp3 players.  Children who skipped 
over the messages or did not listen to their mp3 players at all would not have benefitted from this 
intervention.  While this intervention was not successful, there are some more recent studies that 
have been able to get better results.   
In 2015, Bender et al. conducted a randomized control trial to determine if using voice 
recognition phone calls would improve adherence to LTC medications used to manage persistent 
asthma.  There were 899 participants between the ages of 3-12.  Participants were divided into 
the intervention group and the control group.   
The intervention group received a series of phone calls that were triggered when 
medication refills were two weeks overdue.  The phone calls reminded parents about the 
importance of medications, asked if they needed some assistance with medication refills, and 
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also gave them the option of contacting a pharmacist or an asthma nurse with questions.  The 
control group did not receive phone calls.  The study was continued for two years.  Adherence 
was determined by prescription fill patterns.   
Adherence in the control group was 36% and adherence in the intervention group was 
45%.  The use of voice recognition phone calls did improve adherence, and 84% of parents who 
took the survey said that their child’s asthma was better controlled because of the intervention 
(Bender et al., 2015).  
In 2015, Chan et al. examined adherence to ICS among children between the ages of 6-15 
in New Zealand.  The researchers conducted a randomized control trial that included 220 
participants.  Children in the intervention group received an inhaler that had audiovisual 
reminders.  The inhaler was programmed to know when the LTC medications should be taken.  
If the medication was taken within six hours of its scheduled time there was no reminder.  
However, if it was not taken a ringtone reminder would play.  The ringtone would stop after the 
medication was taken or after 15 minutes.  Children in the control group did not receive the 
electronic reminders.   
The average adherence for the intervention group was 84%.  The average adherence for 
the control group was 30%.  Research has shown that children with well-controlled asthma had a 
median adherence above 80% (Klok et al., 2014), and this intervention was able to change 
behavior enough to achieve those results.  This study suggests that technology may play a pivotal 




A summary of the findings is presented in Table 2.   
Table 2 Findings 
Internal External  Interventional  
Age 
Older adolescents have 
less adherence 
Sex 
Females have more 
adherence 
Race/Ethnicity 
Adherence is less among 
blacks and Hispanics 
Socioeconomic Status 
Adherence is higher among those 
with higher SES 
Environment 
Adherence is lower in urban areas 
Motivation 
Indifference contributes to non-
adherence 
Parental Education 
Children whose parents have 
higher education have higher 
adherence 
Disease Beliefs 
Adherence is higher if parents 
believe that their child needs the 
medication for control 
Medication Beliefs 
Adherence is lower among those 
who have negative beliefs about 
the medications 
Family Dynamics/Planning 
Adherence was higher in families 
that planned medication 
administration and were able to 
problem-solve 
Responsibility 
Adherence was higher among 
families that gradually gave 
responsibility to older children, 
and supervised medication 
administration 
Severity 
The more severe the disease the 
higher the adherence 
Exacerbations 







Knowledge about medications 
increases adherence 
Doctor Visits 
Adherence may increase or 
decrease just prior to a scheduled 
doctor visit 
Specialist 
Adherence was increased in those 
who saw a specialist 
Medications 
Adherence is higher among those 
prescribed leukotriene modifiers 
and lowest among those prescribed 
ICSs 
Multiple Prescriptions 
Adherence declines over time 
when multiple prescriptions are 
given at once 
Asthma Action Plans 
AAP increase adherence 
Symptom Diaries 
Symptom diaries may increase 
adherence 
Technology 
Incorporation of some types of 





It is imperative that all children with persistent asthma receive guideline-based care.  
However, the internal and external factors identified can help HCPs recognize when additional 
barriers can be anticipated.  This foresight can enable HCPs to increase adherence and overall 
quality of life for children with asthma.  It can also lead to reduced costs associated with 
emergency care utilization.   
Interventional factors identified can help HCPs determine what methods are effective and 
what methods are ineffective before making any changes to current practice.   
Communication 
Multiple studies have concluded that improved communication between families and 
HCPs can increase adherence.  That is discussed frequently in the subsequent sections.   
Time  
Multiple studies have suggested that adherence declined over time.  One study reported 
that the more prescriptions provided initially, the lower the adherence.  HCPs should schedule 
follow-up appointments to prevent this trend, especially after a new medication regimen is 
initiated.  During the follow-up HCPs can reassess control, reiterate the importance of the 
medications, and also determine if any new barriers have been identified.    
Race/Ethnicity 
Data reported that there was less adherence among black and Spanish children when 
compared to white children.  HCPs should anticipate cultural barriers among these populations. 
They should anticipate differing perceptions of health and healthcare.  For this reason it is 
important for HCPs to make sure that families agree with the plan of care.  If there are any 
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cultural discrepancies HCPs should compromise and work on a plan that everyone can agree on.     
HCPs should also anticipate language barriers in families if English is not a first language or not 
spoken at all.  In these situation a translator should be used.     
Socioeconomic Status  
The data indicated that medication adherence was lower in families that had a lower SES.  
These families may see money as a barrier, and HCPs should know what community resources 
are available to help these families with medical expenses as well as transportation to obtain the 
prescribed medications.     
Urban or Rural Environment   
One study reported that adherence was lower in urban areas when compared to rural 
areas.  This is possibly due to the more established relationship that rural families have with their 
HCPs.  Communication may be more effective, and better HCP-family communication has been 
shown to have a positive effect on adherence.  Particularly in urban areas, HCPs should work to 
establish relationships with their families and improve communication.   
Parental Education  
The data also reported that medication adherence was lower in families if parents had 
lower levels of education, although some of the data did not specify what was considered lower 
levels of education.  This may be directly related to SES.  If parental education is higher families 
are more likely to have higher SES and not perceive money as a barrier.  If HCPs determine that 
money is preventing families from adhering to medication regimens then they should connect the 
family with local resources, as mentioned before.  If knowledge and understanding is the reason 
for non-adherence then they should provide education.   
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Family Dynamics  
Family dynamics is about planning.  Objective and subjective data was included on this 
topic.  Families had less adherence if they were single-parent families with at least three kids.  
Other families had less adherence if they forgot medication or had problems giving the 
medication, such as child refusal.  HCPs can help the families plan medication administration 
and overcome these barriers.  For example, they might suggest that families set an alarm if 
forgetfulness is the problem.   
Older Adolescents and Responsibility  
Some of the data suggested that toddlers had less adherence when compared to older 
children.  However, there were some studies that did not support this.  More data needs to be 
obtained to form a conclusion.   
The data did consistently point out that older adolescents have less adherence when 
compared to younger adolescents and children.  Data from subjective studies also found that 
adherence declined when parents gave responsibility to older children and adolescents without 
supervision.  In order to overcome this barrier it is suggested that parents be instructed to 
gradually give responsibility to older children and adolescents and to maintain supervision.  It is 
also important for HCPs to incorporate these children when educating families about medications 
and making the treatment plan, because they are also responsible for medication administration.     
Motivation and Disease Beliefs   
These factors are related, and they can all be affected by the HCP to a certain extent.  
Objective and subjective data was obtained for these topics.  Children who were not motivated to 
take their medications stopped taking them.  If parents felt that their child did not need the 
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medication they did not give their child the medication.  HCPs should determine if these children 
do need the medication to obtain control.  If they do then HCPs should educate them about how 
the medication can improve quality of life and decrease the number of exacerbations.  
Understanding may improve motivation and parents may agree that their child does need the 
medication.   
Medication Knowledge and Beliefs    
These factors are also related and can also be affected by the HCP.  Objective and 
subjective data was also obtained for these topics.  Parents in multiple studies expressed 
concerns about the medications.  Adherence was improved if parents knew more about the 
medications.  HCPs should anticipate that if families do not have concerns about the medications 
they will develop concerns after consulting other sources.  That is why HCPs should educate all 
families about the medications that they are prescribed even if there are no questions asked.  
Many of the parents did not know that LTC medications should be taken regularly rather than 
initiated when there is an exacerbation.   
Medications 
Data from the studies consistently suggest that adherence is higher among medication 
regimens that contain leukotriene modifiers and lower among regimens that contain ICSs.  That 
supports the data obtained from objective and subjective studies that indicate that parents do not 
feel comfortable giving their children ICSs.  Unfortunately, data also suggests that ICSs are more 
effective than leukotriene modifiers.  One promising fact is that families with more education 
about ICSs did have higher adherence.  HCPs should specifically educate families about these 
medications, and alleviate any fears or misgivings.   
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Severity and Exacerbations 
Data suggests that adherence increases during an exacerbation and when children have 
more severe asthma.  These children are more symptomatic, and families see that the benefits of 
administering the medication outweigh the risks.  However, HCPs can teach families that it is 
possible to prevent these exacerbations and control the symptoms when medication is given 
regularly.   
Asthma Action Plan (AAP) 
Data suggest that AAPs were beneficial in improving adherence.  AAPs are 
recommended according to national guidelines and should be updated by HCPs at every 
opportunity.    
Specialist or Primary Care 
Data suggests that adherence improved when families went to a specialist rather than a 
general pediatric practitioner.  Also, one subjective study reported that knowledge about the 
medications was also greater if families went to a specialist.  The increased adherence may be 
because parents were more knowledgeable about the medications which has also been shown to 
increase adherence.  HCPs in any setting should ensure that families are knowledgeable about 
their medications and plan of care.   
Symptom Diary 
Data suggests that symptom diaries were beneficial in improving adherence.  However, 
the only data available was based on self-report.  It is recommended that more data be obtained 




Peak flow meters that electronically measured peak expiratory flow after an estimate 
were reported to have a positive effect on adherence.  MP3 players with recorded messages 
providing encouragement did not have a positive effect on adherence.  Data reported that voice 
recognition phone call reminders and inhalers with electronic monitors did have a positive effect 
on adherence.  HCPs should incorporate technology into current practice if it is practical.    





Recommendations for Current Practice 
It is recommended that HCPs in inpatient and outpatient settings incorporate this four-
step process into management of children with persistent asthma to overcome the majority of the 
barriers that have been identified.  To ensure that all of these steps occur routinely it may be 
beneficial to use a prompting form.  An example of a prompting form can be found in the 
appendix.    
1. Assess and Educate 
In this step, HCPs should assess asthma severity and control using guidelines established 
by the NHBLI.  They should also assess knowledge about previously prescribed LTC 
medications and administration technique if applicable.  HCPs should also assess adherence to 
LTC medications used to control persistent asthma.  If relying on patient or caregiver report, 
HCPs should assume that adherence is over-reported.  If patients that are prescribed LTC 
medications have poor asthma control, HCPs should assume that poor adherence is a factor.  
They should also assess for any barriers that may contribute to poor adherence.  As HCPs are 
assessing, they should also be educating, if appropriate.   
2. Collaborate 
This step includes planning or revising a current plan.  This is where the asthma action 
plan can be created.  HCPs should collaborate with the families when making the plan because 
parents consider themselves to be the ultimate decision makers when it comes to caring for their 
children.  If older children or adolescents are responsible for medication administration, they 
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should be included in creating the plan.  HCPs should compromise if there are any 
disagreements. 
3. Problem-Solve 
In the first two steps, barriers to adherence may be identified by families.  In the third 
step, problem solving should be incorporated into the plan.  Identify possible solutions to any 
obstacles that have been identified.  It may be helpful to write this out for parents to reference 
later.  Know the local resources available for parents who cannot afford medications or do not 
have transportation to pick up medications.   
4. Follow-up  
Anything can happen after the family leaves.  That is why it is important for HCPs to 
make follow-up appointments at the time of the visit.  Adherence may decline after the visit for 
innumerable reasons, and it is recommended that adherence be assessed regularly.  Also, a 
follow-up appointment is necessary for HCPs to determine if the prescribed regimen is effective. 
By using these four steps collectively HCPs can potentially overcome most of the barriers 






Recommendations for Future Practice  
In the future, it is recommended that HCPs use data obtained from electronic inhalers to 
objectively monitor adherence rather than relying on reported adherence to modify plans.  The 
reasoning is simple.  If asthma control is poor, and medication adherence is also poor, changing 
the medication regimen is not going to solve the problem.  In order to determine if adherence is 
the problem, HCPs need to be able to monitor adherence objectively. 
 Electronic inhalers are more expensive than traditional inhalers.  However, the objective 
data obtained from the electronic inhalers can help HCPs identify that there are barriers to 
medication adherence even if the families do not readily communicate this.  HCPs could use this 
information to possibly identify barriers to adherence.  If they are able to improve adherence 
asthma control will improve as will quality of life.  Costs from asthma care will also decrease.  




Recommendations for Future Research  
 This review has identified different factors that affect adherence to LTC medications used 
to manage asthma in children.  However, it has not effectively determined why all of these 
factors affect adherence.  Future research should evaluate this.   
 It is recommended that some of the studies presented be repeated to validate the results.  
A study should be done to see if symptom diaries improve adherence when adherence is 
monitored objectively rather than through self-report.  It is also recommended that the study that 
incorporates inhalers that use audio and visual reminders be repeated on a larger scale and with 
various demographics to make the results more generalizable.   
 Future research should also evaluate the effectiveness of using the suggested four-step 





Many research studies excluded participants who did not speak English.  This is a 
limitation because non-adherence caused by cultural or language barriers may be overlooked 
because those participants were excluded.  Also, each study included had its own unique criteria 
for inclusion.  Some studies focused specifically on minorities while other studies focused 
primarily on the Medicaid population.  This increased the generalizability, but it decreased the 
strength of the comparisons.     
Another limitation is that the different studies also had varying measurements of 
adherence.  One study may define adequate adherence as greater than 48% whereas another 
study may define adequate adherence as greater than 80%.  In many studies adherence was 
determined based on prescription fill patterns.  One weakness to that is that receipt of medication 
does not guarantee administration of the medication.  Adherence is likely over-reported in those 
studies.   
Another limitation is that different studies also defined statistical significance differently.  
One study may have described statistically significant data as p=<0.05, and another study may 













Appendix: Example of a Prompting Form That Can Be Used by Healthcare 
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